Press "Enter" to skip to content

Second Investment announced in SafeRx

We are proud to announce that we have just completed our second investment in our portfolio company SafeRX Pharmaceuticals

SafeRX is at the leading edge of the war against opioid abuse. Their platform is designed to deliver a range of Opiod medications that avoid both the danger of being taken (inappropriately) with alcohol and avoiding the body’s natural tendency to need ever growing doses to maintain pain relief.

Hot on the heels of several multi billion dollar lawsuits against pharma companies that have ‘promoted’ widespread supply of drugs (Yahoo news link)

The new investment follows the successful move towards the next step in the regulation map and points to the first trials starting in 2023.

Be First to Comment

Leave a Reply

Your email address will not be published.